Characterization of 5,6- and 8,9-Epoxyeicosatrienoic Acids (5,6- and 8,9-EET) as Potent in Vivo Angiogenic Lipids*
暂无分享,去创建一个
A. Pozzi | J. Falck | J. Capdevila | T. Abair | Shouzuo D. Wei | R. Zent | Yan Su | Ines M. Macias-Perez
[1] J. Falck,et al. Inhibitors of cytochrome P450 4A suppress angiogenic responses. , 2005, The American journal of pathology.
[2] R. Busse,et al. Cytochrome P4502C9-Derived Epoxyeicosatrienoic Acids Induce the Expression of Cyclooxygenase-2 in Endothelial Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[3] P. Pratt,et al. Mechanisms regulating cerebral blood flow as therapeutic targets. , 2004, Current opinion in investigational drugs.
[4] J. Goldstein,et al. CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products , 2004, Journal of Pharmacology and Experimental Therapeutics.
[5] I. Fleming. Cytochrome P450 epoxygenases as EDHF synthase(s). , 2004, Pharmacological research.
[6] D. Seals,et al. Ascorbic acid does not affect large elastic artery compliance or central blood pressure in young and older men. , 2004, American journal of physiology. Heart and circulatory physiology.
[7] J. Falck,et al. Smooth Muscle—Specific Expression of CYP4A1 Induces Endothelial Sprouting in Renal Arterial Microvessels , 2004, Circulation research.
[8] N. Berinstein,et al. Integrating Monoclonal Antibodies into the Management of Mantle Cell Lymphoma. , 2004, Seminars in oncology.
[9] D. Nie,et al. Eicosanoid regulation of angiogenesis in tumors. , 2004, Seminars in thrombosis and hemostasis.
[10] D. Zeldin,et al. Up-Regulation of Endothelial Nitric-Oxide Synthase by Endothelium-Derived Hyperpolarizing Factor Involves Mitogen-Activated Protein Kinase and Protein Kinase C Signaling Pathways , 2003, Journal of Pharmacology and Experimental Therapeutics.
[11] R. Busse,et al. 11,12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p27Kip1* , 2003, Journal of Biological Chemistry.
[12] R. Busse,et al. Cytochrome P450 2C9‐derived epoxyeicosatrienoic acids induce angiogenesis via cross‐talk with the epidermal growth factor receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] D. Harder,et al. Cerebral Capillary Endothelial Cell Mitogenesis and Morphogenesis Induced by Astrocytic Epoxyeicosatrienoic Acid , 2002, Stroke.
[14] A. Pozzi,et al. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo , 2002, Oncogene.
[15] R. Busse,et al. Cytochrome P450 2C9-induced Endothelial Cell Proliferation Involves Induction of Mitogen-activated Protein (MAP) Kinase Phosphatase-1, Inhibition of the c-Jun N-terminal Kinase, and Up-regulation of Cyclin D1* , 2002, The Journal of Biological Chemistry.
[16] Jian-Kang Chen,et al. Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] E. Fosslien. Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. , 2001, Annals of clinical and laboratory science.
[18] J. Goldstein,et al. Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio- and stereoselective products. , 2001, The Journal of pharmacology and experimental therapeutics.
[19] J. Falck,et al. Epoxygenase Metabolites Contribute to Nitric Oxide-Independent Afferent Arteriolar Vasodilation in Response to Bradykinin , 2001, Journal of Vascular Research.
[20] E. Ruoslahti. Targeting tumor vasculature with homing peptides from phage display. , 2000, Seminars in cancer biology.
[21] B D Hammock,et al. Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids , 2000, Circulation research.
[22] A. Pozzi,et al. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Falck,et al. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. , 2000, Journal of lipid research.
[24] R. Busse,et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries , 1999, Nature.
[25] V. Holla,et al. The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. , 1999, The Journal of clinical investigation.
[26] Jian-Kang Chen,et al. Transfection of an Active Cytochrome P450 Arachidonic Acid Epoxygenase Indicates That 14,15-Epoxyeicosatrienoic Acid Functions as an Intracellular Second Messenger in Response to Epidermal Growth Factor* , 1999, The Journal of Biological Chemistry.
[27] Jian-Kang Chen,et al. Epoxyeicosatrienoic Acids and Their Sulfonimide Derivatives Stimulate Tyrosine Phosphorylation and Induce Mitogenesis in Renal Epithelial Cells* , 1998, The Journal of Biological Chemistry.
[28] W. Graier,et al. ORIGIN AND FUNCTION OF EPOXYEICOSATRIENOIC ACIDS IN VASCULAR ENDOTHELIAL CELLS: MORE THAN JUST ENDOTHELIUM‐DERIVED HYPERPOLARIZING FACTOR? , 1998, Clinical and experimental pharmacology & physiology.
[29] J. Falck,et al. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. , 1998, The Journal of pharmacology and experimental therapeutics.
[30] A. A. Spector,et al. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. , 1997, Circulation research.
[31] R. DuBois,et al. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. , 1995, Archives of biochemistry and biophysics.
[32] H. Jacobson,et al. Epoxyeicosatrienoic acids activate Na+/H+ exchange and are mitogenic in cultured rat glomerular mesangial cells , 1990, Journal of cellular physiology.
[33] H. Kleinman,et al. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures , 1988, The Journal of cell biology.
[34] R. Estabrook,et al. The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. , 1983, Archives of biochemistry and biophysics.
[35] E. Wolf,et al. CARP, a cardiac ankyrin repeat protein, is up-regulated during wound healing and induces angiogenesis in experimental granulation tissue. , 2005, The American journal of pathology.
[36] Xiang Fang,et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. , 2004, Progress in lipid research.
[37] R. Busse,et al. Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. , 2003, American journal of physiology. Heart and circulatory physiology.
[38] R. Roman,et al. P-450 metabolites of arachidonic acid in the control of cardiovascular function. , 2002, Physiological reviews.
[39] J. Falck,et al. Cytochrome P450 arachidonic acid epoxygenase: stereochemical characterization of epoxyeicosatrienoic acids. , 1991, Methods in enzymology.
[40] J. Falck,et al. Cytochrome P-450 arachidonate oxygenase. , 1990, Methods in enzymology.